Loading insider details...
Beta
Latest Form 4 (May 23, 2026): Exercise/Conversion of 6,142 ALKS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 23, 2026 | Alkermes plc. (ALKS) | Exercise/Conversion | 6,142 | n/a |
| May 18, 2026 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 8,741 | n/a |
| May 15, 2026 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale | 4,500 | $161.9K |
| Apr 13, 2026 | Alkermes plc. (ALKS) | Exercise/Conversion | 3,751 | n/a |
| Jan 7, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 75,133 | n/a |
| Jan 6, 2026 | EyePoint, Inc. (EYPT) | Exercise/Conversion | 12,666 | n/a |
| Dec 5, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 9,300 | $140.5K |
| Dec 1, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 200 | $3.0K |
| Jul 11, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Exercise/Conversion | 11,111 | n/a |
| Jul 2, 2025 | EyePoint Pharmaceuticals, Inc. (EYPT) | Gift | 31,165 | n/a |